BIOPHARMA
By
Novartis Canada Receives Positive Funding Recommendations for Scemblix® for Chronic Myeloid Leukemia
Montreal, QC – Novartis Canada today announced that the Institut national d’excellence en santé et en services sociaux…
Novartis Announces Agreement with U.S. Government to Support Affordable Access to Medicines
Basel, Switzerland – Novartis, a global leader in innovative medicines, today announced it has reached an agreement with…
BioMarin Announces Agreement to Acquire Amicus Therapeutics in $4.8 Billion Transaction
San Rafael, CA — BioMarin Pharmaceutical Inc. today announced that it has entered into a definitive agreement to…
Bristol Myers Squibb Unveils “Mosaic” AI Content Hub in Mumbai, Advancing Tech-Enabled Patient Engagement
Mumbai, India Bristol Myers Squibb (BMS) today announced the launch of Mosaic, a new artificial intelligence–enabled content hub…
How Is Senhwa Biosciences Using AI and Strategic Collaborations to Shape the Next Generation of Immuno-Oncology?
TAIPEI and SAN DIEGO — Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on first-in-class therapies for oncology,…
Will the European Commission’s New Health Policy Package Accelerate Biotech, AI, and Medical Device Innovation?
The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and resilience across the…
